Cyclooxygenase-2 expression as a prognostic factor in pediatric classical Hodgkin lymphoma.
Yasser El Sayed ElboraiA ElgammalA SalamaM FawzyE D El-DesoukyI AttiaL M ShalabyPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
COX-2 expression showed a tendency to be a poor prognostic factor, but it failed to provide meaningful independent information. Further larger studies are needed to investigate COX-2 as a prognostic factor and potential therapeutic target.